The safety and patients satisfaction of the urinary automatic catheter valve, Mirovalve® in patients with urinary catheter: A randomized clinical trial study

IF 0.5
Hadi Mostafaei , Sepideh Kiani , Zahra Sheikhalipour , Hamidreza Ashayeri , Hanieh Salehi-Pourmehr , Sakineh Hajebrahimi
{"title":"The safety and patients satisfaction of the urinary automatic catheter valve, Mirovalve® in patients with urinary catheter: A randomized clinical trial study","authors":"Hadi Mostafaei ,&nbsp;Sepideh Kiani ,&nbsp;Zahra Sheikhalipour ,&nbsp;Hamidreza Ashayeri ,&nbsp;Hanieh Salehi-Pourmehr ,&nbsp;Sakineh Hajebrahimi","doi":"10.1016/j.contre.2025.100092","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Urinary tract infections (UTIs) are a significant concern for catheterized patients. Catheter valves have been explored as an alternative to traditional drainage bags, with some studies suggesting improved comfort and a potential reduction in UTIs. This study investigated the Mirovalve®, an automatic catheter valve, in a randomized controlled trial. Our objective was to compare the safety, patient satisfaction, and UTI incidence between the Mirovalve® and standard drainage bags.</div></div><div><h3>Methods</h3><div>This randomized clinical trial involved 65 patients with urinary retention requiring catheterization, who were also using diapers due to their underlying condition. The study was conducted in the urology clinics of Tabriz University of Medical Sciences after obtaining informed consent from eligible participants. Patients were randomly assigned to either the control group (urinary catheter connected to a drainage bag) or the therapy group (urinary catheter connected to the Mirovalve® automatic catheter valve). The primary outcomes were safety, assessed by urine culture results at the end of the three-week intervention, and patient satisfaction. Secondary outcomes included the incidence and nature of adverse events. A negative urine culture was confirmed before the study commenced.</div></div><div><h3>Results</h3><div>All 65 participants completed the three-week follow-up. Patient satisfaction was significantly higher in the Mirovalve® group compared to the drainage bag group (P &lt; 0.001). A large majority of Mirovalve® users (73.6 %) reported being \"very\" or \"extremely\" satisfied, versus only 9.7 % of the drainage bag users. The overall incidence of adverse events was similar between the groups, although two patients in the Mirovalve® group experienced temporary acute urinary retention. The incidence of symptomatic UTIs was significantly lower in the Mirovalve® group (12.9 %) compared to the drainage bag group (46.2 %) (P = 0.025).</div></div><div><h3>Conclusion</h3><div>Our findings indicate that the Mirovalve® automatic catheter valve is associated with significantly higher patient satisfaction and a lower incidence of UTIs compared to standard drainage bags. While both methods showed similar short-term safety profiles, the improved satisfaction with the Mirovalve® highlights its potential to enhance patient quality of life. These results suggest that the Mirovalve® is a valuable option for catheter-dependent patients, though further research is needed to confirm these findings over a longer duration and in more diverse populations.</div></div>","PeriodicalId":100330,"journal":{"name":"Continence Reports","volume":"16 ","pages":"Article 100092"},"PeriodicalIF":0.5000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Continence Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772974525000158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Urinary tract infections (UTIs) are a significant concern for catheterized patients. Catheter valves have been explored as an alternative to traditional drainage bags, with some studies suggesting improved comfort and a potential reduction in UTIs. This study investigated the Mirovalve®, an automatic catheter valve, in a randomized controlled trial. Our objective was to compare the safety, patient satisfaction, and UTI incidence between the Mirovalve® and standard drainage bags.

Methods

This randomized clinical trial involved 65 patients with urinary retention requiring catheterization, who were also using diapers due to their underlying condition. The study was conducted in the urology clinics of Tabriz University of Medical Sciences after obtaining informed consent from eligible participants. Patients were randomly assigned to either the control group (urinary catheter connected to a drainage bag) or the therapy group (urinary catheter connected to the Mirovalve® automatic catheter valve). The primary outcomes were safety, assessed by urine culture results at the end of the three-week intervention, and patient satisfaction. Secondary outcomes included the incidence and nature of adverse events. A negative urine culture was confirmed before the study commenced.

Results

All 65 participants completed the three-week follow-up. Patient satisfaction was significantly higher in the Mirovalve® group compared to the drainage bag group (P < 0.001). A large majority of Mirovalve® users (73.6 %) reported being "very" or "extremely" satisfied, versus only 9.7 % of the drainage bag users. The overall incidence of adverse events was similar between the groups, although two patients in the Mirovalve® group experienced temporary acute urinary retention. The incidence of symptomatic UTIs was significantly lower in the Mirovalve® group (12.9 %) compared to the drainage bag group (46.2 %) (P = 0.025).

Conclusion

Our findings indicate that the Mirovalve® automatic catheter valve is associated with significantly higher patient satisfaction and a lower incidence of UTIs compared to standard drainage bags. While both methods showed similar short-term safety profiles, the improved satisfaction with the Mirovalve® highlights its potential to enhance patient quality of life. These results suggest that the Mirovalve® is a valuable option for catheter-dependent patients, though further research is needed to confirm these findings over a longer duration and in more diverse populations.
导尿管患者使用自动导尿管阀Mirovalve®的安全性和患者满意度:一项随机临床试验研究
背景尿路感染(uti)是尿路导尿患者非常关注的问题。导尿管瓣膜已被探索作为传统引流袋的替代品,一些研究表明可以改善舒适性并可能减少尿路感染。本研究在一项随机对照试验中研究了自动导管瓣膜Mirovalve®。我们的目的是比较microvalve®引流袋和标准引流袋的安全性、患者满意度和UTI发生率。方法本随机临床试验纳入65例需要导尿的尿潴留患者,这些患者由于其潜在疾病也使用尿不湿。在获得符合条件的参与者的知情同意后,该研究在大不里士医科大学泌尿科诊所进行。患者被随机分配到对照组(导尿管连接引流袋)或治疗组(导尿管连接Mirovalve®自动导尿管阀)。主要结果是安全性,在三周干预结束时通过尿液培养结果评估,以及患者满意度。次要结局包括不良事件的发生率和性质。在研究开始前确认尿培养阴性。结果65例患者均完成了为期3周的随访。与引流袋组相比,Mirovalve®组患者满意度显著提高(P < 0.001)。绝大多数Mirovalve®用户(73.6%)表示“非常”或“非常”满意,而排水袋用户只有9.7%。尽管Mirovalve®组中有2例患者出现暂时性急性尿潴留,但两组间不良事件的总体发生率相似。症状性尿路感染的发生率在Mirovalve®组(12.9%)显著低于引流袋组(46.2%)(P = 0.025)。结论我们的研究结果表明,与标准引流袋相比,Mirovalve®自动导管阀显著提高了患者满意度,降低了尿路感染的发生率。虽然这两种方法显示出相似的短期安全性,但对Mirovalve®满意度的提高凸显了其提高患者生活质量的潜力。这些结果表明,Mirovalve®是导管依赖患者的一个有价值的选择,尽管需要进一步的研究来证实这些发现在更长的持续时间和更多样化的人群中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信